Action BLAC BELLEVUE LIFE SCIENCES ACQUISITION CORP.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Bellevue Life Sciences Acquisition Corp.

Actions

BLAC

US0791741087

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 07/06/2024 		Varia. 5j. Varia. 1 janv.
10,75 USD +0,09 % Graphique intraday de Bellevue Life Sciences Acquisition Corp. +0,19 % +2,38 %
15/05 Bellevue Life Sciences Acquisition Corp. présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
17/04 Bellevue Life Sciences Acquisition Corp. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.14 million in funding
Bellevue Life Sciences Acquisitions Corp. Reminds Stockholders to Vote in Favor of Extension at May 14, 2024 Stockholder Meeting
Bellevue Life Sciences Acquisition : New Financial Obligation - Form 8-K
/C O R R E C T I O N -- OSR Holdings/
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.05 million in funding
Bellevue Life Sciences Acquisition Corp. announced that it has received $1.2 million in funding
Bellevue Life Sciences Acquisition : New Financial Obligation - Form 8-K
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.06 million in funding
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.075 million in funding
Bellevue Life Sciences Acquisition : OSR Holdings Co., Ltd. Enters Into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp - Form 8-K
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Bellevue Life Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Certain Common Stock of Bellevue Life Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 9-AUG-2023.
Bellevue Life Sciences Acquisition Plans to Take OSR Holdings Public in SPAC Merger Deal
Bellevue Life Sciences Acquisition Corp. and OSR Holdings Sign an Exclusive Letter of Intent for a Business Combination
OSR Holdings.Co.,Ltd. entered into an exclusive, non-binding letter of intent to acquire Bellevue Life Sciences Acquisition Corp. in a reverse merger transaction.
Bellevue Life Sciences Acquisition Corp. announced that it has received $0.2 million in funding
BELLEVUE LIFE SCIENCES ACQUISITION CORP. : Change in Directors or Principal Officers (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BLAC
  4. Actualités Bellevue Life Sciences Acquisition Corp.
  5. Autres langues